FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:814-815 September 12, 1996 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

These are exciting times in neonatology. During the past decade, treatment with exogenous surfactant has improved survival among infants with very low birth weight and respiratory distress syndrome, and new regimens of surfactant treatment and methods of delivery are being developed, as are synthetic surfactants. These advances, along with high-frequency ventilation and inhaled nitric oxide, have resulted in fewer infants who require extracorporeal membrane oxygenation.

Not all infants, however, benefit from surfactant therapy, and questions about the optimal use of surfactant and its optimal composition remain. Surfactant deficiency or pulmonary dysfunction from other causes (sepsis, severe respiratory distress at birth, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.